<p>“Changes in antibody concentrations should influence your therapeutic decision.” Professor Nils Erik Gilhus is joined by Professor Marc De Baets to discuss the importance of regularly measuring autoantibodies to support treatment decisions in people with MG.</p>

“Changes in antibody concentrations should influence your therapeutic decision.” Professor Nils Erik Gilhus is joined by Professor Marc De Baets to discuss the importance of regularly measuring autoantibodies to support treatment decisions in people with MG.

Episode 6 – Autoantibodies as biomarkers

Join our host Professor Nils Erik Gilhus, and a panel of experts in myasthenia gravis (MG) as they discuss a range of medical and clinical challenges related to the management of MG. 

Coming soon - Professor Maria Teressa Ferretti will be joined by her friend and MG patient Maya Uccheddu, to discuss patient perspective and the burden of this disease.

This content is intended for Healthcare Professionals only. Not intended for US audiences.

Education

Join our host Professor Nils Erik Gilhus, and a panel of experts in myasthenia gravis (MG) as they discuss a range of medical and clinical challenges related to the management of MG. Coming soon - Professor Maria Teressa Ferretti will be joined by her friend and MG patient Maya Uccheddu, to discuss patient perspective and the burden of this disease. This content is intended for Healthcare Professionals only. Not intended for US audiences.

Share Episode 6 – Autoantibodies as biomarkers

Sign up to save your podcasts

Episode 6 – Autoantibodies as biomarkers

Episode 6 – Autoantibodies as biomarkers

More shows like Unlocking Myasthenia gravis

Clinician's Brief: The Podcast

Medscape InDiscussion: Myasthenia Gravis